Related Experiment Video
Updated: Oct 9, 2025
08:34
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
15.3K
THE EFFECT OF ADIPONECTIN VIA REGULATING THE BONE MICROENVIRONMENT OXIDATIVE STRESS ON OSTEOGENESIS IN TYPE 2
1Taiyuan Central Hospital, Department of Endocrinology, Shanxi Medical University, Shanxi, China.
Acta Endocrinologica (Bucharest, Romania : 2005)
|December 20, 2021
Summary
Adiponectin intervention improved bone structure in type 2 diabetic rats by reducing oxidative stress and enhancing osteogenesis markers. This suggests adiponectin may protect bone health in diabetes.
Area of Science:
- Endocrinology
- Bone Biology
- Diabetology
Background:
- Type 2 diabetes is associated with impaired bone metabolism and increased fracture risk.
- Oxidative stress plays a significant role in the pathogenesis of diabetic complications, including bone disease.
Purpose of the Study:
- To investigate the therapeutic effect of adiponectin on osteogenesis in a rat model of type 2 diabetes.
- To explore the underlying mechanisms involving oxidative stress and bone formation markers.
Main Methods:
- Type 2 diabetes was induced in Sprague-Dawley rats using a high-fat/high-sugar diet and streptozotocin.
- Rats were treated with adiponectin and assessed for bone microstructure, bone mineral density, and expression of osteogenesis markers (Runx-2, BALP).
- Oxidative stress markers (AOPP, AGEs) were measured in bone marrow.
Main Results:
- Diabetic rats exhibited increased blood glucose, oxidative stress markers (AOPP, AGEs), and decreased bone mineral density, Runx-2 mRNA, and BALP levels.
- Adiponectin treatment significantly reduced oxidative stress markers and increased osteogenesis markers.
- Bone microstructure analysis revealed moderate restoration of trabecular bone structure in the adiponectin-treated group.
Conclusions:
- Oxidative stress in the bone microenvironment of diabetic rats inhibits osteogenic differentiation factor Runx2, leading to reduced bone formation.
- Adiponectin demonstrates potential as a therapeutic agent to mitigate oxidative stress and protect bone structure in type 2 diabetes.
